Linezolid

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB

Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease

Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort

Evaluating Newly Approved Drugs for Multidrug-resistant TB

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

Treatment Shortening of MDR-TB Using Existing and New Drugs